Outcome after PET-CT based radiotherapy for non-small cell lung cancer;Wyniki radioterapii planowanej na podstawie badania PET-CT u chorych na niedrobnokomórkowego raka płuca

Pneumonologia i Alergologia Polska

Volumn 81, Issue 1, 2013, Pages 30-39

  Socha, Joanna ^a,b   Kołodziejczyk, Milena ^a   Kepka, Lucyna ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b Cz stochowskie Centrum Onkologii   (Poland)

Author keywords

Isolated nodal failure; Non small cell lung cancer; PET CT; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POLAND; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLAND; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84871530369     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. MacManus M.P., Hicks R.J., Ball D.L. i wsp. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001; 92: 886-895.
2. Reed C.E., Harpole D.H., Posther K.E. i wsp. for the American College of Surgeons Oncology Group: Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2003; 126: 1943-1951.
3. Giraud P., Grahek D., Montravers F. i wsp. CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 1249-1257.
4. Bradley J., Thorstad W.L., Mutic S. i wsp. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004; 59: 78-86.
5. Kołodziejczyk M., Ke{ogonek}pka L., Dziuk M. i wsp. Impact of [18F] fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non small-cell lung cancer: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 2011; 80: 1008-1014.
6. MacManus M.P., Hicks R.J., Matthews J.P. i wsp. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2001; 50: 287-293.
7. MacManus M.P., Wong K., Hicks R.J., Matthews J.P., Wirth A., Ball D.L. Early mortality after radical radiotherapy for nonsmall-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center. Int. J. Radiat. Oncol. Biol. Phys. 2002; 52: 351-361.
8. Eschmann S.M., Friedel G., Paulsen F. i wsp. Impact of staging with 18F-FDG-PET on outcome of patients with stage III nonsmall cell lung cancer: PET identifies potential survivors. Eur. J. Nucl. Med. Mol. Imaging. 2007; 34: 54-59.
9. Ung Y., Gu C.S., Cline K. i wsp. An Ontario Clinical Oncology Group (OCOG) randomized trial of FDG PET-CT in stage III non-small-cell lung cancer (NSCLC): impact of PET on survival. J. Clin. Oncol. 2011; 29 (15 supl.): abstract 7018.
10. Fischer B., Lassen U., Mortensen J. i wsp. Preoperative staging of lung cancer with combined PET-CT. N. Engl. J. Med. 2009; 361: 32-39.
11. Ke{ogonek}pka L., Tyc-Szczepaniak D., Bujko K. Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer. J. Thorac. Oncol. 2009; 4: 853-861.
12. Chapet O., Kong F.M., Quint L.E. i wsp. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int. J. Radiat. Oncol. Biol. Phys. 2005; 63: 170-178.
13. Ke{ogonek}pka L., Bujko K., Garmol D. i wsp. Delineation variation of lymph node stations for treatment planning in lung cancer radiotherapy. Radiother. Oncol. 2007; 85: 450-455.
14. Van Baardwijk A., Wanders S., Boersma L i wsp. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. J. Clin. Oncol. 2010; 28: 1380-1386.
15. Videtic G.M., Rice T.W., Murthy S. i wsp. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort. Int. J. Radiat. Oncol. Biol. Phys. 2008; 72: 702-706.
16. Ryu J.S., Choi N.C., Fischman A.J., Lynch T.J., Mathisen D.J. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 2002; 35: 179-187.
17. MacManus M.P., Hicks R.J., Matthews J.P., Wirth A., Rischin D., Ball D.L. Metabolic (FDG-PET) response after radical radiotherapy/ chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer 2005; 49: 95-108
18. Kołodziejczyk M., Ke{ogonek}pka L., Tyc-Szczepaniak D., Wierzchowski M. Wyniki konformalnej radioterapii chorych na niedrobnokomórkowego raka płuca we wczesnym stopniu zaawansowania spełniaja{ogonek}cych kryteria oraz niespełniaja{ogonek}cych kryteriów kwalifikacji do napromieniania stereotaktycznego. Pneumonol. Alergol. Pol. 2011; 79: 326-336.
19. Bradley J., Bae K., Choi N. i wsp. A Phase II Comparative Study of Gross Tumor Volume Definition With or Without PET/CT Fusion in Dosimetric Planning for Non-small-cell Lung Cancer (NSCLC): Primary Analysis of Radiation Therapy Oncology Group (RTOG) 0515. Int. J. Radiat. Oncol. Biol. Phys. 2012; 82: 435-441.
20. De Ruysscher D., Wanders S., van Haren E. i wsp. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study. Int. J. Radiat. Oncol. Biol. Phys. 2005; 62: 988-994.